Paeoniflorin attenuates allergic inflammation in asthmatic mice

International Immunopharmacology

Volumn 24, Issue 1, 2014, Pages 88-94

  Sun, Jing ^a   Wu, Jinfeng ^a   Xu, Changqing ^b   Luo, Qingli ^a   Li, Bei ^a   Dong, Jingcheng ^a  

^a FUDAN UNIVERSITY   (China)

^b HANGZHOU FIRST PEOPLE'S HOSPITAL   (China)

Author keywords

APK; L 13; L 17; L 5; Paeoniflorin; sthma

Indexed keywords

EOTAXIN; IMMUNOGLOBULIN E; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 5; METHACHOLINE; MITOGEN ACTIVATED PROTEIN KINASE; OVALBUMIN; PAEONIFLORIN; STRESS ACTIVATED PROTEIN KINASE; AUTACOID; CCL11 PROTEIN, MOUSE; CYTOKINE; GLUCOSIDE; NONSTEROID ANTIINFLAMMATORY AGENT; TERPENE;

AIRWAY RESISTANCE; ALLERGIC AIRWAY INFLAMMATION; ALLERGIC ASTHMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DRUG EFFECT; DRUG MEGADOSE; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHILIA; FEMALE; GENE ACTIVATION; GENE EXPRESSION; HISTOLOGY; IMMUNOGLOBULIN BLOOD LEVEL; INFLAMMATORY CELL; LOW DRUG DOSE; LUNG FUNCTION; LUNG LAVAGE; LUNG PARENCHYMA; MOUSE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RESPIRATORY TRACT ALLERGY; UPREGULATION; WESTERN BLOTTING; ANIMAL; ASTHMA; BAGG ALBINO MOUSE; BRONCHIAL HYPERREACTIVITY; DISEASE MODEL; DOWN REGULATION; DRUG EFFECTS; GENETICS; IMMUNOLOGY; INHALATION TEST; LUNG; METABOLISM; ORAL DRUG ADMINISTRATION; PAEONIA;

ADMINISTRATION, ORAL; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASTHMA; BRONCHIAL HYPERREACTIVITY; BRONCHIAL PROVOCATION TESTS; CHEMOKINE CCL11; CYTOKINES; DISEASE MODELS, ANIMAL; DOWN-REGULATION; FEMALE; GLUCOSIDES; INFLAMMATION MEDIATORS; LUNG; MICE; MICE, INBRED BALB C; MONOTERPENES; PAEONIA;

EID: 84915809574     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2014.11.016     Document Type: Article

References (35)

1. R.M. Pascual, and S.P. Peters Airway remodeling contributes to the progressive loss of lung function in asthma: an overview J Allergy Clin Immunol 116 2005 477 486 [quiz 87]
2. C. Bergeron, W. Al-Ramli, and Q. Hamid Remodeling in asthma Proc Am Thorac Soc 6 2009 301 305
3. S.A. Shore Modeling airway remodeling: the winner by a nose? Am J Respir Crit Care Med 168 2003 910 911
4. Y. Kikkawa, K. Sugiyama, K. Obara, H. Hirata, Y. Fukushima, and M. Toda Interferon-alpha inhibits airway eosinophilia and hyperresponsiveness in an animal asthma model [corrected] Asia Pac Allergy 2 2012 256 263
5. P.J. Barnes Pathophysiology of allergic inflammation Immunol Rev 242 2011 31 50
6. S.S. Possa, E.A. Leick, C.M. Prado, M.A. Martins, and I.F. Tiberio Eosinophilic inflammation in allergic asthma Front Pharmacol 4 2013 46
7. A. Kanda, V. Driss, N. Hornez, M. Abdallah, T. Roumier, and G. Abboud Eosinophil-derived IFN-gamma induces airway hyperresponsiveness and lung inflammation in the absence of lymphocytes J Allergy Clin Immunol 124 2009 573 582 [82 e1-9]
8. G.M. Walsh Targeting eosinophils in asthma: current and future state of cytokine- and chemokine-directed monoclonal therapy Expert Rev Clin Immunol 6 2010 701 704
9. B. Lee, Y.W. Shin, E.A. Bae, S.J. Han, J.S. Kim, and S.S. Kang Antiallergic effect of the root of Paeonia lactiflora and its constituents paeoniflorin and paeonol Arch Pharm Res 31 2008 445 450
10. T.T. Kung, B. Luo, Y. Crawley, C.G. Garlisi, K. Devito, and M. Minnicozzi Effect of anti-mIL-9 antibody on the development of pulmonary inflammation and airway hyperresponsiveness in allergic mice Am J Respir Cell Mol Biol 25 2001 600 605
11. X. Chen, T. Wen, J. Wei, Z. Wu, P. Wang, and Z. Hong Treatment of allergic inflammation and hyperresponsiveness by a simple compound, Bavachinin, isolated from Chinese herbs Cell Mol Immunol 10 2013 497 505
12. L. Bielory Complementary and alternative interventions in asthma, allergy, and immunology Ann Allergy Asthma Immunol 93 2004 S45 S54
13. S.H. Yang, C.Y. Hong, and C.L. Yu Decreased serum IgE level, decreased IFN-gamma and IL-5 but increased IL-10 production, and suppressed cyclooxygenase 2 mRNA expression in patients with perennial allergic rhinitis after treatment with a new mixed formula of Chinese herbs Int Immunopharmacol 1 2001 1173 1182
14. X. Li, J. Shen, Z. Zhong, J. Peng, H. Wen, and J. Li Paeoniflorin ameliorates schistosomiasis liver fibrosis through regulating IL-13 and its signalling molecules in mice Parasitology 137 2010 1213 1225
15. R.K. Kumar, and P.S. Foster Modeling allergic asthma in mice: pitfalls and opportunities Am J Respir Cell Mol Biol 27 2002 267 272
16. M. Pichavant, S. Goya, E. Hamelmann, E.W. Gelfand, and D.T. Umetsu Animal models of airway sensitization John E. Coligan, Current protocols in immunology 2007 [Chapter 15:Unit 15 8]
17. K.H. Albertine, L. Wang, S. Watanabe, G.K. Marathe, G.A. Zimmerman, and T.M. McIntyre Temporal correlation of measurements of airway hyperresponsiveness in ovalbumin-sensitized mice Am J Physiol Lung Cell Mol Physiol 283 2002 L219 L233
18. S. Underwood, M. Foster, D. Raeburn, S. Bottoms, and J.A. Karlsson Time-course of antigen-induced airway inflammation in the guinea-pig and its relationship to airway hyperresponsiveness Eur Respir J 8 1995 2104 2113
19. J.A. Hirota, T.L. Hackett, M.D. Inman, and D.A. Knight Modeling asthma in mice: what have we learned about the airway epithelium? Am J Respir Cell Mol Biol 44 2011 431 438
20. D.Y. He, and S.M. Dai Anti-inflammatory and immunomodulatory effects of Paeonia lactiflora Pall., a traditional Chinese herbal medicine Front Pharmacol 2 2011 10
21. M.J. Schuijs, M.A. Willart, H. Hammad, and B.N. Lambrecht Cytokine targets in airway inflammation Curr Opin Pharmacol 13 2013 351 361
22. E.A. Jacobsen, R.A. Helmers, J.J. Lee, and N.A. Lee The expanding role(s) of eosinophils in health and disease Blood 120 2012 3882 3890
23. P.C. Fulkerson, and M.E. Rothenberg Targeting eosinophils in allergy, inflammation and beyond Nat Rev Drug Discov 12 2013 117 129
24. C. Palmqvist, A.J. Wardlaw, and P. Bradding Chemokines and their receptors as potential targets for the treatment of asthma Br J Pharmacol 151 2007 725 736
25. D.M. Conroy, and T.J. Williams Eotaxin and the attraction of eosinophils to the asthmatic lung Respir Res 2 2001 150 156
26. L. Hemelaers, and R. Louis Eotaxin: an important chemokine in asthma Rev Med Liege 61 2006 223 226
27. J. Corren Inhibition of interleukin-5 for the treatment of eosinophilic diseases Discov Med 13 2012 305 312
28. P. Flood-Page, A. Menzies-Gow, S. Phipps, S. Ying, A. Wangoo, and M.S. Ludwig Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics J Clin Invest 112 2003 1029 1036
29. J.L. Ingram, and M. Kraft IL-13 in asthma and allergic disease: asthma phenotypes and targeted therapies J Allergy Clin Immunol 130 2012 829 842 [quiz 43-4]
30. R.G. Townley, M. Sapkota, and K. Sapkota IL-13 and its genetic variants: effect on current asthma treatments Discov Med 12 2011 513 523
31. H.L. Tan, and M. Rosenthal IL-17 in lung disease: friend or foe? Thorax 68 2013 788 790
32. G.L. Johnson, and R. Lapadat Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases Science 298 2002 1911 1912
33. K.F. Chung p38 mitogen-activated protein kinase pathways in asthma and COPD Chest 139 2011 1470 1479
34. W. Duan, and W.S. Wong Targeting mitogen-activated protein kinases for asthma Curr Drug Targets 7 2006 691 698
35. Z.Q. Liu, Z.H. Jiang, L. Liu, and M. Hu Mechanisms responsible for poor oral bioavailability of paeoniflorin: role of intestinal disposition and interactions with sinomenine Pharm Res 23 2006 2768 2780